Physician profile
Peter Lementowski
NPI 1942366943
$6,844.98
in general payments reported to CMS, 2019-2025
14 companies · $677 in 2025
The $677 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,654 · 2020: $617 · 2021: $853 · 2022: $686 · 2023: $837 · 2024: $1,522 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,487 · Travel and Lodging: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.62 |
| Travel and Lodging | $548.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,583.48 | 2019-2025 | Mako, Triathlon, Accolade |
| Zimmer Biomet Holdings, INC. | $1,607.87 | 2019-2025 | Persona, Avenir |
| Globus Medical, INC. | $832.28 | 2024-2025 | Proven Gen-Flex Ps Knee System, Excelsius Gps, Actify 3d |
| Depuy Synthes Sales INC. | $723.33 | 2019-2025 | Na, Multiloc, Tfn-Advance |
| Smith+Nephew, INC. | $512.28 | 2019-2024 | Legion Revision, Collagenase Santyl, Pico |
| Axogen | $166.28 | 2021 | |
| Bone Support INC. | $103.97 | 2024 | Ceramentbone Void Filler, Cerament G |
| Molnlycke Health Care US, LLC | $98.19 | 2023-2024 | Avance, Mepilex Border Post-Op Ag, Mepilex Border Ag |
| Intellijoint Surgical INC. | $66.67 | 2019 | |
| Orthofix Medical, INC. | $43.57 | 2023 | Spinal-Stim, Spinal-Stim |
| Ethicon US, LLC | $33.72 | 2024 | Vistaseal, Ethicon, Stratafix |
| Integra Lifesciences Corporation | $30.51 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $30.39 | 2022 | |
| Innovation Technologies INC | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lementowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.